Register entry

GlaxoSmithKline Biologicals SA

Registered sites
19
Drug products
126
Live patents
63
Countries
9
Base
United Kingdom
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackagingparticle size reductionsterilize
Sites

Facilities

19
SiteLocationOperationsFEI
GlaxoSmithKline Biologicals SARixensartBelgiumAnalytical testing, Labelling, Finished drug manufacture, Packaging, sterilize3002875226
GlaxoSmithKline Biologicals SAWavreBelgiumAnalytical testing, Labelling, Finished drug manufacture, Packaging, sterilize3003973577
ID Biomedical Corporation of QuebecSte-FoyCanadaAnalytical testing, Labelling, Finished drug manufacture, Packaging, sterilize3004835647
SmithKline Beecham Pharma GmbH & Co. KG (dba GlaxoSmithKline Biologicals)DresdenGermanyAnalytical testing, Finished drug manufacture, Packaging, sterilize3004835618
GSK Vaccines GmbHMarburgGermanyAnalytical testing, Finished drug manufacture, Packaging3001314775
Glaxo Wellcome S.A.Aranda De DueroSpainAnalytical testing, Labelling, Finished drug manufacture, Packaging3004195227
Glaxo Wellcome ProductionEvreuxFranceAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, particle size reduction3002807436
GlaxoSmithKline BiologicalsSaint-Amand Les EauxFranceAnalytical testing, Labelling, Finished drug manufacture, Packaging3014752610
Glaxo Operations UK LtdBarnard CastleUnited KingdomAnalytical testing, Labelling, Finished drug manufacture, Packaging, sterilize3002807078
Glaxo Operations UK LtdMontroseUnited KingdomAnalytical testing, Active ingredient (API) manufacture3003215057
Glaxo Operations UK LtdStevenageUnited KingdomAnalytical testing3009763376
Glaxo Operations UK LtdWareUnited KingdomAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, particle size reduction3003262904
GlaxoSmithKline Vaccines SrlSOVICILLE (ROSIA )ItalyAnalytical testing, Labelling, Finished drug manufacture, Packaging3006738517
GlaxoSmithKline Manufacturing SpASan PoloItalyAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize3002807114
GSK Vaccines S.r.l.SienaItalyAnalytical testing3007780504
Glaxo Wellcome Manufacturing Pte. LtdJurongSingaporeAnalytical testing, Active ingredient (API) manufacture, particle size reduction3002807079
GlaxoSmithKline LLCConshohocken, PAUnited StatesAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize3004055938
Corixa CorporationMarietta, PAUnited StatesAnalytical testing, Labelling, Finished drug manufacture, Packaging, sterilize3007726770
GlaxoSmithKline LLCZebulon, NCUnited StatesAnalytical testing, Labelling, Finished drug manufacture, Packaging1033964
Exclusivity

Patents

63

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
BLUJEPAGEPOTIDACIN MESYLATEFeb 2029
BLUJEPAGEPOTIDACIN MESYLATEAug 2035
BLUJEPAGEPOTIDACIN MESYLATEDec 2042
BREXAFEMMEIBREXAFUNGERP CITRATEAug 2030
BREXAFEMMEIBREXAFUNGERP CITRATEJan 2035
BREXAFEMMEIBREXAFUNGERP CITRATEJun 2039
LAMICTAL XRLAMOTRIGINEJan 2029
OJJAARAMOMELOTINIB DIHYDROCHLORIDEJan 2035
OJJAARAMOMELOTINIB DIHYDROCHLORIDEJun 2035
OJJAARAMOMELOTINIB DIHYDROCHLORIDEAug 2039
OJJAARAMOMELOTINIB DIHYDROCHLORIDEDec 2040
UTEBZITEBIPENEM PIVOXIL HYDROBROMIDEDec 2037
UTEBZITEBIPENEM PIVOXIL HYDROBROMIDEFeb 2038
ZEJULANIRAPARIB TOSYLATEAug 2027
ZEJULANIRAPARIB TOSYLATEApr 2029
ZEJULANIRAPARIB TOSYLATEMar 2031
ZEJULANIRAPARIB TOSYLATEAug 2031
ZEJULANIRAPARIB TOSYLATEMar 2038
ZEJULANIRAPARIB TOSYLATEJan 2039
Catalogue

Marketed products

126

Showing 126 of 126.

BrandGeneric nameFormCategory
ADVAIR DISKUSfluticasone propionate and salmeterolPOWDERNDA
ADVAIR DISKUSfluticasone propionate and salmeterolPOWDERNDA
ADVAIR DISKUSfluticasone propionate and salmeterolPOWDERNDA
ADVAIR HFAfluticasone propionate and salmeterol xinafoateAEROSOL, METEREDNDA
ADVAIR HFAfluticasone propionate and salmeterol xinafoateAEROSOL, METEREDNDA
ADVAIR HFAfluticasone propionate and salmeterol xinafoateAEROSOL, METEREDNDA
AS03AS03INJECTION, SOLUTIONUNAPPROVED DRUG OTHER
Anoro Elliptaumeclidinium bromide and vilanterol trifenatatePOWDERNDA
ArepanrixInfluenza A H5 Monovalent VaccineKITBLA
ArexvyRespiratory Syncytial Virus Vaccine Recombinant, AdjuvantedKITBLA
ArexvyRespiratory Syncytial Virus Vaccine Recombinant, AdjuvantedKITBLA
ArexvyRespiratory Syncytial Virus Vaccine Recombinant, AdjuvantedKITBLA
Arnuity Elliptafluticasone furoatePOWDERNDA
Arnuity Elliptafluticasone furoatePOWDERNDA
Arnuity Elliptafluticasone furoatePOWDERNDA
BENLYSTAbelimumabSOLUTIONBLA
BENLYSTAbelimumabINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONBLA
BENLYSTAbelimumabINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONBLA
BOOSTRIXTetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, AdsorbedSUSPENSIONBLA
BexseroNEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGENINJECTION, SUSPENSIONBLA
Blenrepbelantamab mafodotinINJECTION, POWDER, FOR SOLUTIONBLA
BlujepagepotidacinTABLET, FILM COATEDNDA
Breo Elliptafluticasone furoate and vilanterol trifenatatePOWDERNDA
Breo Elliptafluticasone furoate and vilanterol trifenatatePOWDERNDA
Breo Elliptafluticasone furoate and vilanterol trifenatatePOWDERNDA
-DepemokimabLIQUIDBULK INGREDIENT
-Dolutegravir and LamivudineTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
ENGERIX-BHepatitis B Vaccine (Recombinant)INJECTION, SUSPENSIONBLA
ENGERIX-BHepatitis B Vaccine (Recombinant)INJECTION, SUSPENSIONBLA
ExdensurdepemokimabINJECTION, SOLUTIONBLA
FLUARIX 2026/2027influenza virus vaccineSUSPENSIONBLA
HAVRIXHepatitis A VaccineINJECTION, SUSPENSIONBLA
HAVRIXHepatitis A VaccineINJECTION, SUSPENSIONBLA
HiberixHaemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)KITBLA
HiberixHaemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)KITBLA
IMITREXsumatriptanINJECTIONNDA
IMITREXsumatriptanINJECTIONNDA
IMITREXsumatriptanTABLET, FILM COATEDNDA
IMITREXsumatriptanTABLET, FILM COATEDNDA
IMITREXsumatriptanTABLET, FILM COATEDNDA
IMITREXsumatriptanINJECTIONNDA
INFANRIXDiphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine AdsorbedSUSPENSIONBLA
Incruse ElliptaumeclidiniumAEROSOL, POWDERNDA
JemperlidostarlimabINJECTIONBLA
JesduvroqdaprodustatTABLET, FILM COATEDNDA
JesduvroqdaprodustatTABLET, FILM COATEDNDA
JesduvroqdaprodustatTABLET, FILM COATEDNDA
JesduvroqdaprodustatTABLET, FILM COATEDNDA
JesduvroqdaprodustatTABLET, FILM COATEDNDA
KINRIXDiphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus VaccineINJECTION, SUSPENSIONBLA
Krintafeltafenoquine succinateTABLET, FILM COATEDNDA
LAMICTALlamotrigineTABLET, FOR SUSPENSIONNDA
LAMICTALlamotrigineTABLET, FOR SUSPENSIONNDA
LAMICTALlamotrigineKITNDA
LAMICTALlamotrigineTABLETNDA
LAMICTALlamotrigineTABLETNDA
LAMICTALlamotrigineTABLETNDA
LAMICTALlamotrigineTABLETNDA
LAMICTALlamotrigineTABLET, FOR SUSPENSIONNDA
LAMICTALlamotrigineKITNDA
LAMICTAL ODTlamotrigineTABLET, ORALLY DISINTEGRATINGNDA
LAMICTAL ODTlamotrigineTABLET, ORALLY DISINTEGRATINGNDA
LAMICTAL ODTlamotrigineTABLET, ORALLY DISINTEGRATINGNDA
LAMICTAL ODTlamotrigineTABLET, ORALLY DISINTEGRATINGNDA
LAMICTAL ODTlamotrigineKITNDA
LAMICTAL ODTlamotrigineKITNDA
LAMICTAL ODTlamotrigineKITNDA
LAMICTAL XRlamotrigineTABLET, FILM COATED, EXTENDED RELEASENDA
LAMICTAL XRlamotrigineTABLET, FILM COATED, EXTENDED RELEASENDA
LAMICTAL XRlamotrigineTABLET, FILM COATED, EXTENDED RELEASENDA
LAMICTAL XRlamotrigineTABLET, FILM COATED, EXTENDED RELEASENDA
LAMICTAL XRlamotrigineKITNDA
LAMICTAL XRlamotrigineKITNDA
LAMICTAL XRlamotrigineKITNDA
LAMICTAL XRlamotrigineTABLET, FILM COATED, EXTENDED RELEASENDA
LAMICTAL XRlamotrigineTABLET, FILM COATED, EXTENDED RELEASENDA
MALARONEatovaquone and proguanil hydrochlorideTABLET, FILM COATEDNDA
MALARONEatovaquone and proguanil hydrochlorideTABLET, FILM COATEDNDA
MEPRONatovaquoneSUSPENSIONNDA
MEPRONatovaquoneSUSPENSIONNDA
MenveoMeningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate VaccineINJECTION, SOLUTIONBLA
MenveoMeningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate VaccineKITBLA
NucalamepolizumabINJECTION, POWDER, FOR SOLUTIONBLA
NucalamepolizumabINJECTION, SOLUTIONBLA
NucalamepolizumabINJECTION, SOLUTIONBLA
OjjaaraMomelotinibTABLETNDA
OjjaaraMomelotinibTABLETNDA
OjjaaraMomelotinibTABLETNDA
PEDIARIXDiphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine CombinedINJECTION, SUSPENSIONBLA
PENMENVYMeningococcal (Groups A, B, C, W and Y)KITBLA
PriorixMeasels, Mumps, and Rubella Vaccine, LiveKITBLA
RELENZAzanamivirPOWDERNDA
RotarixRotavirus Vaccine, Live, OralSOLUTIONBLA
SEREVENT DISKUSsalmeterol xinafoatePOWDER, METEREDNDA
ShingrixZoster Vaccine Recombinant, AdjuvantedKITBLA
ShingrixZoster Vaccine Recombinant, AdjuvantedINJECTION, SOLUTIONBLA
TWINRIXHepatitis A and Hepatitis B (Recombinant) VaccineINJECTION, SUSPENSIONBLA
Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatatePOWDERNDA
Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatatePOWDERNDA
VALTREXvalacyclovir hydrochlorideTABLET, FILM COATEDNDA
VALTREXvalacyclovir hydrochlorideTABLET, FILM COATEDNDA
VENTOLIN HFAalbuterol sulfateAEROSOL, METEREDNDA
WELLBUTRIN SRbupropion hydrochlorideTABLET, FILM COATEDNDA
WELLBUTRIN SRbupropion hydrochlorideTABLET, FILM COATEDNDA
WELLBUTRIN SRbupropion hydrochlorideTABLET, FILM COATEDNDA
ZEJULAniraparibTABLET, FILM COATEDNDA
ZEJULAniraparibTABLET, FILM COATEDNDA
ZEJULAniraparibTABLET, FILM COATEDNDA
-belantamab mafodotinLIQUIDBULK INGREDIENT
-belimumabLIQUIDBULK INGREDIENT
-doxorubicin hydrochlorideINJECTION, SUSPENSION, LIPOSOMALDRUG FOR FURTHER PROCESSING
-lamotrigineTABLET, FILM COATED, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-lamotrigineTABLET, FILM COATED, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-lamotrigineTABLET, FILM COATED, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-lamotrigineTABLET, FILM COATED, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-lamotrigineTABLETDRUG FOR FURTHER PROCESSING
-lamotrigineTABLETDRUG FOR FURTHER PROCESSING
-mepolizumabLIQUIDBULK INGREDIENT
-mepolizumabLIQUIDBULK INGREDIENT
-mepolizumabLIQUIDBULK INGREDIENT
-raxibacumabLIQUIDBULK INGREDIENT
-sumatriptanTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-sumatriptanTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-sumatriptanTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-trametinibTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-trametinibTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.